The role of vitamin D towards immune tolerance in white adipose tissue (WAT)

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 15, Issue 4, 2015, Pages 277-287

  Chirumbolo, Salvatore ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b Policlinico GB Rossi   (Italy)

Author keywords

Calcitriol; Leptin; T reg cells; Tolerance; Vitamin D; White adipose tissue

Indexed keywords

1BETA,25 DIHYDROXYCOLECALCIFEROL; CALCIFEDIOL; COLECALCIFEROL; CXCL14 CHEMOKINE; GHRELIN; LEPTIN; VITAMIN D; ADIPOCYTOKINE; CALCITRIOL;

ADIPOCYTE; ARTICLE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MUCOSAL IMMUNITY; SECRETION (PROCESS); STOMACH MUCOSA;

ADIPOKINES; ADIPOSE TISSUE, WHITE; ANIMALS; CALCIFEDIOL; CALCITRIOL; GASTRIC MUCOSA; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; LEPTIN; MACROPHAGES; MODELS, IMMUNOLOGICAL; NATURAL KILLER T-CELLS; T-LYMPHOCYTES, REGULATORY; VITAMIN D;

EID: 84959550785     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530315666150701113811     Document Type: Article

References (166)

1. Masoodi, M.; Kuda, O.; Rossmeisl, M.; Flachs, P.; Kopecky, J. Lipid signaling in adipose tissue: Connecting inflammation & metabolism. Biochim. Biophys. Acta., 2014, 1851(4), 503-518.
2. Exley, M.A.; Hand, L.; O'Shea, D.; Lynch, L. Interplay between the immune system and adipose tissue in obesity. J. Endocrinol., 2014, 223(2), R41-R48.
3. Huh, J.Y.; Park, Y.J.; Ham, M.; Kim, J.B. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol. Cells., 2014, 37(5), 365-371.
4. Straub, R.H. Interaction of the endocrine system with inflammation: a function of energy and volume regulation. Arthritis Res. Ther., 2014, 16(1), 203.
5. Lee, B.C.; Lee, J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim. Biophys. Acta., 2014, 1842(3), 446-462.
6. Hersoug, L.G.; Linneberg, A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy, 2007, 62(10), 1205-1213.
7. Scotece, M.; Conde, J.; Gómez, R.; López, V.; Lago, F.; Gómez-Reino, J.J.; Gualillo, O. Beyond fat mass: exploring the role of adipokines in rheumatic diseases. ScientificWorldJournal, 2011, 11, 1932-1947
8. Mai, X.M.; Chen, Y.; Krewski, D. Does leptin play a role in obesity-asthma relationship? Pediatr. Allergy Immunol., 2009, 20(3), 207-212.
9. de Luis, D.A.; Soto, G.D.; Conde, R.; Izaola, O.; de la Fuente, B. Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. J. Clin. Lab. Anal., 2012, 26(5), 398-402.
10. Ghavamzadeh, S.; Mobasseri, M.; Mahdavi, R. The Effect of Vitamin D Supplementation on Adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients. Int. J. Prev. Med., 2014, 5(9), 1091-1098.
11. Edita, S.; Aleksandar, K.; Dragana, T.N.; Dragana, S.; Branka, K.Z.; Biljana, S.G.; Sanja, S.; Esma, I.R. Vitamin D and Dysfunctional Adipose Tissue in Obesity. Angiology, 2014, 22, 613-618.
12. Vilarrasa, N.; Vendrell, J.; Maravall, J.; Elío, I.; Solano, E.; San José, P.; García, I.; Virgili, N.; Soler, J.; Gómez, J.M. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine, 2010, 38(2), 235-242.
13. Terrier, B.; Derian N.; Schoindre Y.; Chaara W.; Geri G.; Zahr N.; Mariampillai K.; Rosenzwajg M.; Carpentier W.; Musset L.; Piette J.C.; Six A.; Klatzmann D.; Saadoun D.; Patrice C.; Costedoat-Chalumeau N. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther., 2012, 14(5), R221.
14. Székely J.I.; Pataki Á. Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review. Expert Rev. Respir. Med., 2012, 6(6), 683-704.
15. Yang, C.Y.; Leung, P.S.; Adamopoulos, I.E.; Gershwin, M.E. The implication of vitamin D and autoimmunity: a comprehensive review. Clin. Rev. Allergy Immunol., 2013, 45(2), 217-226.
16. Agmon-Levin, N.; Theodor, E.; Segal, R.M.; Shoenfeld, Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin. Rev. Allergy Immunol., 2013, 45(2), 256-266.
17. Amarilyo, G.; Iikuni, N.; Liu, A.; Matarese, G.; La Cava, A. Leptin Enhances Availability of Apoptotic Cell-Derived Self-Antigen in Systemic Lupus Erythematosus. PLoS One, 2014, 9(11), e112826.
18. Amarilyo, G.; Iikuni, N.; Shi, F.D.; Liu, A.; Matarese, G.; La Cava, A. Leptin promotes lupus T-cell autoimmunity. Clin. Immunol., 2013, 149(3), 530-533.
19. Kong, J.; Chen, Y.; Zhu, G.; Zhao, Q.; Li, Y.C. 1,25-Dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J. Endocrinol., 2013, 216(2), 265-271.
20. Cutolo, M.; Paolino, S.; Sulli, A.; Smith, V.; Pizzorni, C.; Seriolo, B. Vitamin D, steroid hormones, and autoimmunity. Ann. N Y Acad Sci., 2014, 1317, 39-46.
21. Morris, D.L.; Cho, K.W.; Delproposto, J.L.; Oatmen, K.E.; Geletka, L.M.; Martinez-Santibanez, G.; Singer, K.; Lumeng, C.N. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes, 2013, 62(8), 2762-2772.
22. Priceman, S.J.; Kujawski, M.; Shen, S.; Cherryholmes, G.A.; Lee, H.; Zhang, C.; Kruper, L.; Mortimer, J.; Jove, R.; Riggs, A.D.; Yu, H. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc. Natl. Acad. Sci. USA, 2013, 110(32), 13079-13084.
23. Winer, D.A.; Winer, S.; Chng, M.H.; Shen, L.; Engleman, E.G. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol. Life Sci., 2014, 71(6), 1033-1043
24. Ding, C.; Gao, D.; Wilding, J.; Trayhurn, P.; Bing, C. Vitamin D signalling in adipose tissue. Br. J. Nutr., 2012, 108(11), 1915-1923
25. Matsunuma, A.; Horiuchi, N. Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1alpha-hydroxylase in mice via the long form of the leptin receptor. Arch. Biochem. Biophys., 2007, 463(1), 118-27
26. Tsuji, K.; Maeda, T.; Kawane, T.; Matsunuma, A.; Horiuchi, N. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J. Bone Miner. Res., 2010, 25(8), 1711-1723.
27. Sun, X.; Zemel M.B. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J. Nutr. Biochem., 2008, 19(6), 392-399.
28. Narvaez, C.J.; Simmons, K.M.; Brunton, J.; Salinero, A.; Chittur, S.V.; Welsh, J.E. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J. Cell Physiol., 2013, 228(10), 2024-2036.
29. Matarese, G.; Procaccini, C.; De Rosa, V. At the crossroad of T cells, adipose tissue, and diabetes. Immunol. Rev., 2012, 249(1), 116-134.
30. Pucino, V.; De Rosa, V.; Procaccini, C.; Matarese, G. Regulatory T cells, leptin and angiogenesis. Chem. Immunol. Allergy., 2014, 99, 155-169.
31. Matarese, G.; Procaccini, C.; De Rosa, V.; Horvath, T.L.; La Cava, A. Regulatory T cells in obesity: the leptin connection. Trends Mol. Med., 2010, 16(6), 247-256.
32. De Rosa, V.; Procaccini, C.; Cali, G.; Pirozzi, G.; Fontana, S.; Zappacosta, S.; La Cava, A.; Matarese, G. A key role of leptin in the control of regulatory T cell proliferation. Immunity, 2007, 26(2), 241-255.
33. Cipolletta, D. Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology, 2014, 142(4), 517-525.
34. Fernández-Riejos, P.; Najib, S.; Santos-Alvarez, J.; Martín-Romero, C.; Pérez-Pérez, A.; González-Yanes, C.; Sánchez-Margalet, V. Role of leptin in the activation of immune cells. Mediators Inflamm., 2010, 2010, 568343.
35. Schäffler, A.; Schölmerich, J.; Salzberger, B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol., 2007, 28(9), 393-399.
36. Schäffler, A.; Schölmerich, J. Innate immunity and adipose tissue biology. Trends Immunol., 2010, 31(6), 228-235.
37. Alexaki, V.I.; Notas, G.; Pelekanou, V.; Kampa, M.; Valkanou, M.; Theodoropoulos, P.; Stathopoulos, E.N.; Tsapis, A.; Castanas, E. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. J. Immunol., 2009, 183(9), 5948-5956.
38. Nagai, Y.; Watanabe, Y.; Takatsu, K. The TLR family protein RP105/MD-1 complex: A new player in obesity and adipose tissue inflammation. Adipocyte, 2013, 2(2), 61-66.
39. Pietsch, J.; Batra, A.; Stroh, T.; Fedke, I.; Glauben, R.; Okur, B.; Zeitz, M.; Siegmund, B. Toll-like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation. Ann. N. Y. Acad. Sci., 2006, 107, 407-409.
40. Yin, Z; Deng, T.; Peterson, L.E.; Yu, R.; Lin, J.; Hamilton, D.J.; Reardon, P.R.; Sherman, V.; Winnier, G.E.; Zhan, M.; Lyon, C.J.; Wong, S.T.; Hsueh, W.A. Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesityinduced adipose inflammation. Mol. Cell. Endocrinol., 2014, 394(1-2), 80-87.
41. Fujiya, A.; Nagasaki, H.; Seino, Y.; Okawa, T.; Kato, J.; Fukami, A.; Himeno, T.; Uenishi, E.; Tsunekawa, S.; Kamiya, H.; Nakamura, J.; Oiso Y.; Hamada Y. The role of S100B in the interaction between adipocytes and macrophages. Obesity (Silver Spring), 2014, 22(2), 371-379.
42. Goncalves, C.A.; Leite, M.C.; Guerra, M.C. Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue. Cardiovas.c Psychiatry Neurol., 2010, 2010, 790431.
43. Razolli, D.S.; Moraes, J.C.; Morari, J.; Moura, R.F.; Vinolo, M.A.; Velloso, L.A. TLR4 expression in bone marrow-derived cells is both necessary and sufficient to produce the insulin resistance phenotype in diet-induced obesity. Endocrinology, 2014, en20141552.
44. Jialal I.; Kaur H.; Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J. Clin. Endocrinol. Metab., 2014, 99(1), 39-48.
45. Murillo, G.; Nagpal, V.; Tiwari, N.; Benya, R.V.; Mehta, R.G. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. J. Steroid. Biochem. Mol. Biol., 2010, 121(1-2), 403-407.
46. Chirumbolo, S.; Franceschetti, G.; Zoico, E.; Bambace, C.; Cominacini, L.; Zamboni, M. LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model. Inflamm. Res., 2014, 63(6), 495-507.
47. Zoico, E.; Di Francesco, V.; Olioso, D.; Fratta Pasini, A.M.; Sepe, A.; Bosello, O.; Cinti, S.; Cominacini, L.; Zamboni, M. In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation. Biogerontology, 2010, 11(1), 111-122.
48. Meijer, K.; de Vries, M.; Al-Lahham, S.; Bruinenberg, M.; Weening, D.; Dijkstra, M.; Kloosterhuis, N.; van der Leij, R.J.; van der Want, H.; Kroesen, B.J.; Vonk, R.; Rezaee, F. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One, 2011, 6(3), e17154.
49. Coppack S.W. Pro-inflammatory cytokines and adipose tissue. Proc. Nutr. Soc., 2001, 60(3), 349-356.
50. Alexandraki, K.; Piperi, C.; Kalofoutis, C.; Singh, J.; Alaveras, A.; Kalofoutis, A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann. N. Y. Acad. Sci., 2006 1084, 89-117.
51. Cullberg, K.B.; Larsen, J.Ø.; Pedersen, S.B.; Richelsen, B. Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro. Nutr. Diabetes., 2014, 4, e113
52. Miki, Y.; Ono, K.; Hata, S.; Suzuki, T.; Kumamoto, H.; Sasano, H. The advantages of co-culture over mono cell culture in simulating in vivo environment. J. Steroid Biochem. Mol. Biol., 2012, 131(3-5), 68-75.
53. Fite, A.; Abou-Samra, A.B.; Seyoum, B. Macrophages Inhibit Insulin Signalling in Adipocytes: Role of Inducible Nitric Oxide Synthase and Nitric Oxide. Can. J. Diabetes., 2014, 39(1), 36-43.
54. Sanada, Y.; Kumoto, T.; Suehiro, H.; Yamamoto, T.; Nishimura, F.; Kato, N.; Yanaka, N. IκB kinase psilon expression in adipocytes is upregulated by interaction with macrophages. Biosci. Biotechnol. Biochem., 2014, 78(8), 1357-1362.
55. Exley, M.A.; Hand, L.: O'Shea, D.; Lynch L. Interplay between the immune system and adipose tissue in obesity. J. Endocrinol., 2014, 223(2), R41-R48.
56. Hill, A.A.; Reid Bolus, W.; Hasty, A.H. A decade of progress in adipose tissue macrophage biology. Immunol. Rev., 2014, 262(1), 134-52
57. Anderson, E.K.; Gutierrez, D.A.; Hasty, A.H. Adipose tissue recruitment of leukocytes. Curr. Opin. Lipidol., 2010, 21(3), 172-177.
58. Lumeng, C.N.; Del, Proposto J.B.; Westcott, D.J.; Saltiel, A.R. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes, 2008, 57(12), 3239-3246.
59. Akira, S.; Misawa, T.; Satoh, T.; Saitoh, T. Macrophages control innate inflammation. Diabetes Obes. Metab., 2013, 15 Suppl 3, 10-18.
60. Titos, E.; Rius, B.; González-Périz, A.; López-Vicario, C.; Morán-Salvador, E.; Martínez-Clemente, M.; Arroyo, V.; Clària, J. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol., 2011, 187(10), 5408-5418.
61. Kraakman, M.J.; Murphy, A.J.; Jandeleit-Dahm, K.; Kammoun, H.L. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol., 2014, 5, 470.
62. Heilbronn, L.K.; Campbell, L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm, Des., 2008, 14(12), 1225-1230.
63. Vieira-Potter, V.J. Inflammation and macrophage modulation in adipose tissues. Cell Microbiol., 2014, 16(10), 1484-1492.
64. Patel, P.S.; Buras, E.D.; Balasubramanyam, A. The role of the immune system in obesity and insulin resistance. J. Obes., 2013, 2013, 616193
65. Han, L.; Tang, M.X.; Ti, Y.; Wang, Z.H.; Wang, J.; Ding, W.Y.; Wang, H.; Zhang, Y.; Zhang, W.; Zhong, M. Overexpressing STAMP2 improves insulin resistance in diabetic ApoE-/-/LDLR-/-mice via macrophage polarization shift in adipose tissues. PLoS One. 2013, 8(11), e78903.
66. Arner, P.; Stenson, B.M.; Dungner, E.; Näslund, E.; Hoffstedt, J.; Ryden, M.; Dahlman, I. Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance. J. Clin. Endocrinol. Metab., 2008, 93(6), 2249-2254.
67. Moreno-Navarrete, J.M; Ortega, F.; Serrano, M.; Pérez-Pérez, R.; Sabater, M.; Ricart, W.; Tinahones, F.; Peral, B.; Fernández-Real, J.M. Decreased STAMP2 expression in association with visceral adipose tissue dysfunction. J. Clin. Endocrinol. Metab., 2011, 96(11), E1816-E1825.
68. Giangreco, A.A.; Dambal, S.; Wagner, D.; Van der Kwast, T.; Vieth, R.; Prins, G.S.; Nonn, L. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model. J. Steroid Biochem. Mol. Biol., 2014, 148, 156-165.
69. Krishnan, A.V.; Peehl, D.M.; Feldman, D. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression. J. Cell. Biochem., 2003, 88(2), 363-371.
70. Mutt, S.J.; Hyppönen, E.; Saarnio, J.; Järvelin, M.R.; Herzig, K.H. Vitamin D and adipose tissue-more than storage. Front Physiol., 2014, 5, 228.
71. Zhang, X.L.; Guo, Y.F.; Song, Z.X.; Zhou, M. Vitamin D Prevents Podocyte Injury Via Regulation Of Macrophage M1/M2 Phenotype In Diabetic Nephropathy Rats. Endocrinology, 2014, 155(12), 4939-4950.
72. Banica, L.M.; Besliu, A.N.; Pistol, G.C.; Stavaru, C.; Vlad, V.; Predeteanu, D., Ionescu, R.; Stefanescu, M.; Matache, C. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells. Int. J. Rheum. Dis., 2010, [Epub ahead of print]
73. Yuzefpolskiy, Y.; Baumann, F.M.; Penny, L.A.; Studzinski, G.P.; Kalia, V.; Sarkar, S. Vitamin D Receptor Signals Regulate Effector and Memory CD8 T Cell Responses to Infections in Mice. J. Nutr., 2014, 144(12), 2073-2082.
74. Yu, S.; Cantorna, M.T. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J. Immunol., 2011, 186(3), 1384-1390.
75. Lynch, L. Adipose invariant natural killer T cells. Immunology., 2014, 142(3), 337-346.
76. Lynch, L.; Nowak, M.; Varghese, B.; Clark, J.; Hogan, A.F.; Toxavidis, V.; Balk, S.P.; O’Shea, D.; O’Farrelly, C.; Exley, M.A. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity, 2012, 37, 574-587.
77. Ooi, J.H.; Chen, J.; Cantorna, M.T. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol. Aspects Med., 2012, 33(1), 77-82.
78. Cantorna, M.T. Why do T cells express the vitamin D receptor? Ann. N. Y. Acad. Sci., 2011, 1217, 77-82.
79. Yu, S.; Cantorna, M.T. The vitamin D receptor is required for iNKT cell development. Proc. Natl. Acad. Sci. USA, 2008, 105(13), 5207-5212.
80. Lorente-Cebrián, S.; Eriksson, A.; Dunlop, T.; Mejhert, N.; Dahlman, I.; Aström, G.; Sjölin, E.; Wåhlén, K.; Carlberg, C.; Laurencikiene, J.; Hedén, P.; Arner, P.; Rydén, M. Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur. J. Nutr., 2012, 51(3), 335-342.
81. Zoico, E.; Franceschetti, G.; Chirumbolo, S.; Rossi, A.P.; Mazzali, G.; Rizzatti, V.; Budui, S.; Zamboni M. Phenotypic shift of adipocytes by cholecalciferol and 1α,25 dihydroxycholecalciferol in relation to inflammatory status and calcium content. Endocrinology, 2014, 155(11), 4178-4188.
82. Ting, H.J.; Yasmin-Karim, S.; Yan, S.J.; Hsu, J.W.; Lin, T.H.; Zeng, W.; Messing, J.; Sheu, T.J.; Bao, B.Y.; Li, W.X.; Messing, E.; Lee, Y.F. A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D. Cancer Res., 2012, 72(4), 958-968.
83. Kershaw, E.E.; Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 2004, 89(6), 2548-2556.
84. Zeng, H.; Chi, H. The interplay between regulatory T cells and metabolism in immune regulation. Oncoimmunology, 2013, 2(11), e26586
85. Zeng, H.; Chi, H. Metabolic control of regulatory T cell development and function. Trends Immunol., 2015, 36(1), 3-12
86. De Rosa, V.; Procaccini, C.; Calì, G.; Pirozzi, G.; Fontana, S.; Zappacosta, S.; La Cava, A.; Matarese, G. A key role of leptin in the control of regulatory T cell proliferation. Immunity, 2007, 26(2), 241-255.
87. Procaccini, C.; De Rosa, V.; Galgani, M.; Carbone, F.; Cassano, S.; Greco, D.; Qian, K.; Auvinen, P.; Cali, G.; Stallone, G.; Formisano, L.; La Cava, A.; Matarese, G. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J. Immunol., 2012, 189(6), 2941-2953.
88. Wada, N.; Hirako, S.; Takenoya, F.; Kageyama, H.; Okabe, M.; Shioda, S. Leptin and its receptors. J. Chem. Neuroanat., 2014, 61-62, 191-199.
89. Suzukawa, M.; Nagase, H.; Ogahara, I.; Han, K.; Tashimo, H.; Shibui, A.; Koketsu, R.; Nakae, S.; Yamaguchi, M.; Ohta, K. Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J. Immunol., 2011, 186(9), 5254-5260.
90. Cayrol, C.; Girard, J.P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol., 2014, 31C, 31-37.
91. Cipolletta, D.; Kolodin, D.; Benoist, C.; Mathis, D. Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin. Immunol., 2011, 23(6), 431-437.
92. Procaccini, C.; De Rosa, V.; Galgani, M.; Carbone, F.; La Rocca, C.; Formisano, L.; Matarese, G. Role of adipokines signaling in the modulation of T cells function. Front. Immunol., 2013, 4, 332.
93. Piccio, L.; Cantoni, C.; Henderson, J.G.; Hawiger, D.; Ramsbottom, M.; Mikesell, R.; Ryu, J.; Hsieh, C.S.; Cremasco, V.; Haynes, W.; Dong, L.Q.; Chan, L.; Galimberti, D.; Cross, A.H. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. Eur. J. Immunol., 2013, 43(8), 2089-2100.
94. Caglayan, E.; Romeo, G.R.; Kappert, K.; Odenthal, M.; Sudkamp, M.; Body, S.C.; Shernan, S.K.; Hackbusch, D.; Vantler, M.; Kazlauskas, A.; Rosenkranz, S. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One, 2010, 5(10), e13608.
95. Ye, F.; Zhang, H.; Yang, Y.X.; Hu, H.D.; Sze, S.K.; Meng, W.; Qian, J.; Ren, H.; Yang, B.L.; Luo, M.Y.; Wu, X.; Zhu, W.; Cai, W.J.; Tong, J.B. Comparative proteome analysis of 3T3-L1 adipocyte differentiation using iTRAQ-coupled 2D LC-MS/MS. J. Cell. Biochem., 2011, 112(10), 3002-3014.
96. Pae, M.; Romeo, G.R. The multifaceted role of profilin-1 in adipose tissue inflammation and glucose homeostasis. Adipocyte, 2014, 3(1), 69-74.
97. Romeo, G.R.; Pae, M.; Eberlé, D.; Lee, J.; Shoelson, S.E. Profilin-1 haplo-insufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes, 2013, 62(11), 3718-3726.
98. Pettersson, U.S.; Waldén, T.B.; Carlsson, P.O.; Jansson, L.; Phillipson, M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One, 2012, 7(9), e46057.
99. Wolff, M.J.; Leung, J.M.; Davenport, M.; Poles, M.A.; Cho, I.; Loke, P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS One, 2012, 7(7), e41373
100. Wernstedt Asterholm, I.; Tao, C.; Morley, T.S.; Wang, Q.A.; Delgado-Lopez, F.; Wang, Z.V.; Scherer, P.E. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell. Metab., 2014, 20(1), 103-118.
101. Engela, A.U.; Hoogduijn, M.J.; Boer, K.; Litjens, N.H.; Betjes, M.G.; Weimar, W.; Baan, C.C. Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. Clin. Exp. Immunol., 2013, 173(2), 343-354.
102. Kamata, S.; Miyagawa, S.; Fukushima, S.; Imanishi, Y.; Saito, A.; Maeda, N.; Shimomura, I.; Sawa, Y. Targeted Delivery of Adipocytokines Into the Heart by Induced Adipocyte Cell-Sheet Transplantation Yields Immune Tolerance and Functional Recovery in Autoimmune-Associated Myocarditis in Rats. Circ. J., 2014, 79(1), 169-179.
103. Nakajima, H.; Nakajima, K.; Tarutani, M.; Sano, S. Clear association between serum levels of adipokines and T-helper 17-related cytokines in patients with psoriasis. Clin. Exp. Dermatol., 2013, 38(1), 66-70.
104. Hara T.; Nakayama Y. CXCL14 and insulin action. Vitam. Horm., 2009, 80, 107-123.
105. Zhou, F.; Lauretti, E.; di Meco, A.; Ciric, B.; Gonnella, P.; Zhang, G.X.; Rostami, A. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity. Immunobiology, 2013, 218(8), 1069-1076.
106. Lamers, D.; Famulla, S.; Wronkowitz, N.; Hartwig, S.; Lehr, S.; Ouwens, D.M.; Eckardt, K.; Kaufman, J.M.; Ryden, M.; Muller, S.; Hanisch, F.G.; Ruige, J.; Arner, P.; Sell, H.; Eckel, J. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes, 2011, 60(7), 1917-1925.
107. Zhong, J.; Rao, X.; Deiuliis, J.; Braunstein, Z.; Narula, V.; Hazey, J.; Mikami, D.; Needleman, B.; Satoskar, A.R.; Rajagopalan, S. A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes, 2013, 62(1), 149-157.
108. Tejera-Alhambra, M.; Casrouge, A.; de Andrés, C.; Ramos-Medina, R.; Alonso, B.; Vega, J.; Albert, M.L.; Sánchez-Ramón, S. Low DPP4 expression and activity in multiple sclerosis. Clin. Immunol., 2014, 150(2), 170-183.
109. Lee, M.S. Treatment of autoimmune diabetes by inhibiting the initial event. Immune Netw., 2013, 13(5), 194-198.
110. Milani, C.; Katayama, M.L.; de Lyra, E.C.; Welsh, J.; Campos, L.T.; Brentani, M.M.; Maciel Mdo, S.; Roela, R.A.; del Valle, P.R.; Goes, J.C.; Nonogaki, S.; Tamura, R.E.; Folgueira, M.A. Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer, 2013, 13, 119.
111. Murakami, K, Bujo, H, Unoki, H, Saito, Y. High fat intake induces a population of adipocytes to co-express TLR2 and TNFalpha in mice with insulin resistance. Biochem. Biophys. Res. Commun., 2007, 354(3), 727-734.
112. Kim, D.H.; Lee, J.C.; Kim, S.; Oh, S.H.; Lee, M.K.; Kim, K.W.; Lee, M.S. Inhibition of autoimmune diabetes by TLR2 tolerance. J. Immunol., 2011, 187(10), 5211-5220.
113. Girgis, C.M.; Clifton-Bligh R.J.; Hamrick M.W.; Holick M.F.; Gunton J.E. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev., 2013, 34(1), 33-83.
114. van der Velde, R.Y.; Brouwers, J.R.; Geusens, P.P.; Lems, W.F.; van den Bergh, J.P. Calcium and vitamin D supplementation: state of the art for daily practice. Food Nutr. Res., 2014, 58, 10.
115. Bendik, I.; Friedel, A.; Roos, F.F.; Weber, P.; Eggersdorfer, M. Vitamin D: a critical and essential micronutrient for human health. Front Physiol., 2014, 5, 248.
116. Hanson, J.R. Steroids: partial synthesis in medicinal chemistry. Nat. Prod. Rep., 2010, 27(6), 887-899.
117. Okano, T.; Yasumura, M.; Mizuno, K.; Kobayashi, T. In vivo and in vitro conversion of 7-dehydrocholesterol into vitamin D3 in rat skin by ultraviolet ray's irradiation. J. Nutr. Sci. Vitaminol. (Tokyo), 1978, 24(1), 47-56.
118. Olds, W.J.; McKinley, A.R.; Moore, M.R.; Kimlin, M.G. In vitro model of vitamin D3 (cholecalciferol) synthesis by UV radiation: dose-response relationships. J. Photochem. Photobiol. B., 2008, 93(2), 88-93.
119. Nimitphong, H.; Holick, M.F.; Fried, S.K.; Lee, M.J. 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 promote the differentiation of human subcutaneous preadipocytes. PLoS One, 2012, 7(12), e52171
120. Sun, X.; Zemel, M.B. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J. Nutr. Biochem., 2008, 19(6), 392-399.
121. Riek, A.E.; Oh, J.; Darwech, I.; Moynihan, C.E.; Bruchas, R.R.; Bernal-Mizrachi, C. 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J. Steroid Biochem. Mol. Biol., 2014, 144 Pt A, 172-179.
122. Morris, A.; Selvaraj, R.K. In vitro 25-hydroxycholecalciferol treatment of lipopolysaccharide-stimulated chicken macrophages increases nitric oxide production and mRNA of interleukin-1beta and 10. Vet. Immunol. Immunopathol., 2014, 161(3-4), 265-270.
123. Kearns, M.D.; Alvarez, J.A.; Seidel, N.; Tangpricha V. Impact of Vitamin D on Infectious Disease: A Systematic Review of Controlled Trials. Am. J. Med. Sci., 2015, 349(3), 245-262.
124. Ding, C.; Wilding, J.P.; Bing C. 1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes. PLoS One, 2013, 8(4), e61707
125. Marcotorchino, J.; Gouranton, E.; Romier, B.; Tourniaire, F.; Astier, J.; Malezet, C.; Amiot, M.J.; Landrier, J.F. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol. Nutr. Food Res., 2012, 56(12), 1771-1782.
126. Mutt, S.J.; Karhu, T.; Lehtonen, S.; Lehenkari, P.; Carlberg, C.; Saarnio, J.; Sebert, S.; Hypponen, E.; Jarvelin, M.R.; Herzig, K.H. Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D3 via the NF-κB pathway. FASEB J., 2012, 26(11), 4400-4407.
127. Mocanu, V.; Oboroceanu, T.; Zugun-Eloae, F. Current status in vitamin D and regulatory T cells--immunological implications. Rev. Med. Chir. Soc. Med. Nat. Iasi., 2013, 117(4), 965-973.
128. D'Aurizio, F.; Villalta, D.; Metus, P.; Doretto, P.; Tozzoli, R. Vitamin D is a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun. Rev., 2015, 14(5), 363-9
129. Mazokopakis E.E.; Kotsiris D.A. Hashimoto's autoimmune thyroiditis and vitamin D deficiency. Current aspects. Hell J. Nucl. Med., 2014, 17(1), 37-40.
130. Ota, K.; Dambaeva, S.; Han, A.R.; Beaman, K.; Gilman-Sachs, A.; Kwak-Kim, J. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum. Reprod., 2014, 29(2), 208-219.
131. Versini, M.; Jeandel, P.Y.; Rosenthal, E.; Shoenfeld, Y. Obesity in autoimmune diseases: Not a passive bystander. Autoimmun. Rev., 2014, 13(9), 981-1000.
132. Lira, F.S.; Rosa, J.C.; Cunha, C.A.; Ribeiro, E.B.; do Nascimento, C.O.; Oyama, L.M.; Mota, J.F. Supplementing alpha-tocopherol (vitamin E) and vitamin D3 in high fat diet decrease IL-6 production in murine epididymal adipose tissue and 3T3-L1 adipocytes following LPS stimulation. Lipids Health Dis., 2011, 10, 37.
133. Vielma, S.A.; Klein, R.L.; Levingston, C.A.; Young, M.R. Adipocytes as immune regulatory cells. Int. Immunopharmacol., 2013, 16(2), 224-231.
134. Walker, G.E.; Ricotti, R.; Roccio, M.; Moia, S.; Bellone, S.; Prodam, F.; Bona, G. Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PLoS One, 2014, 9(1), e83685.
135. Belenchia, A.M.; Tosh, A.K.; Hillman, L.S.; Peterson, C.A.; Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am. J. Clin. Nutr., 2013, 97(4), 774-781.
136. Mizrahi, M.; Shabat, Y.; Ben Ya'acov, A.; Lalazar, G.; Adar, T.; Wong, V.; Muller, B.; Rawlin, G.; Ilan, Y. Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH. J. Inflamm. Res., 2012, 5, 141-150.
137. Schipper, H.S.; Rakhshandehroo, M.; van de Graaf, S.F.; Venken, K.; Koppen, A.; Stienstra, R.; Prop, S.; Meerding, J.; Hamers, N.; Besra, G.; Boon, L.; Nieuwenhuis, E.E.; Elewaut, D.; Prakken, B.; Kersten, S.; Boes, M.; Kalkhoven, E. Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest., 2012, 122(9), 3343-3354.
138. Cantorna, M.T.; Zhao, J.; Yang, L. Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc. Nutr. Soc., 2012, 71(1), 62-66.
139. Kongsbak, M.; Levring, T.B.; Geisler, C.; von Essen, M.R. The vitamin d receptor and T cell function. Front. Immunol., 2013, 4, 148.
140. Kongsbak, M.; von Essen, M.R.; Boding, L.; Levring, T.B.; Schjerling, P.; Lauritsen, J.P.; Woetmann, A.; Ødum, N.; Bonefeld, C.M.; Geisler, C. Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells. PLoS One, 2014, 9(5), e96695.
141. Lynch, L.; O’Shea, D.; Winter, D.C.; Geoghegan, J.; Doherty, D.G.; O’Farrelly, C. Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol., 2009, 39, 1893-1901.
142. Sag, D.; Krause, P.; Hedrick, C.C.; Kronenberg M.; Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest., 2014, 124(9), 3725-40.
143. Kundu, R.; Chain, B.M.; Coussens, A.K.; Khoo, B.; Noursadeghi, M. Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur. J. Immunol., 2014, 44(6), 1781-1790.
144. Cammisotto, P.G.; Levy, E.; Bukowiecki, L.J.; Bendayan, M. Cross-talk between adipose and gastric leptins for the control of food intake and energy metabolism. Prog. Histochem. Cytochem., 2010, 45(3), 143-200.
145. Cammisotto, P.G.; Bendayan, M. Leptin secretion by white adipose tissue and gastric mucosa. Histol. Histopathol., 2007, 22(2), 199-210.
146. Cammisotto, P.; Bendayan, M. A review on gastric leptin: the exocrine secretion of a gastric hormone. Anat. Cell. Biol., 2012, 45(1), 1-16.
147. Singh, U.P.; Singh, N.P.; Guan, H.; Busbee, B.; Price, R.L.; Taub, D.D.; Mishra, M.K.; Fayad, R.; Nagarkatti, M.; Nagarkatti, P.S. Leptin antagonist ameliorates chronic colitis in IL-10-/-mice. Immunobiology, 2013, 218(12), 1439-1451.
148. Yan, X.; Liu, Z.; Chen, Y. Regulation of TGF-beta signaling by Smad7. Acta. Biochim. Biophys. Sin. (Shanghai), 2009, 41(4), 263-272.
149. Fantini, M.C.; Rizzo, A.; Fina, D.; Caruso, R.; Sarra, M.; Stolfi, C.; Becker, C.; Macdonald, T.T.; Pallone, F.; Neurath, M.F.; Monteleone, G. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology, 2009, 136(4), 1308-1316.
150. Sobhani, I.; Bado, A.; Vissuzaine, C.; Buyse, M.; Kermorgant, S.; Laigneau, J.P.; Attoub, S.; Lehy, T.; Henin, D.; Mignon, M.; Lewin, M.J. Leptin secretion and leptin receptor in the human stomach. Gut, 2000, 47(2), 178-183.
151. Walduck, A.K.; Becher, D. Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection. Front. Immunol., 2012, 3, 316.
152. Sakar, Y.; Nazaret, C.; Lettéron, P.; Ait Omar, A.; Avenati, M.; Viollet, B.; Ducroc, R.; Bado, A. Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents. PLoS One, 2009, 4(11), e7935.
153. Fathy, S.M.; Morshed, G. Peripheral blood lymphocyte subsets (CD4+, CD8+ T cells), leptin level and weight loss after laparoscopic greater curvature plication in morbidly obese patients. Arch. Med. Sci., 2014, 10(5), 886-890.
154. Stieg, M.R.; Sievers, C.; Farr, O.; Stalla, G.K.; Mantzoros, C.S. Leptin: A hormone linking activation of neuroendocrine axes with neuropathology. Psychoneuroendocrinology, 2014, 51C, 47-57.
155. Borer, K.T. Counterregulation of insulin by leptin as key component of autonomic regulation of body weight. World J. Diabetes, 2014, 5(5), 606-629.
156. Acedo, S.C.; Gambero, S.; Cunha, F.G.; Lorand-Metze, I.; Gambero, A. Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk. In Vitro Cell Dev. Biol. Anim., 2013, 49(6), 473-478.
157. López-Jaramillo, P.; Gómez-Arbeláez, D.; López-López, J.; López-López, C.; Martínez-Ortega, J.; Gómez-Rodríguez, A.; Triana-Cubillos S. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm. Mol. Biol. Clin. Investig., 2014, 18(1), 37-45.
158. Saini, R.K.; Kaneko, I.; Jurutka, P.W.; Forster, R.; Hsieh, A.; Hsieh, J.C.; Haussler, M.R.; Whitfield, G.K. 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. Calcif. Tissue Int., 2013, 92(4), 339-353.
159. Quarles, L.D. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp. Cell Res., 2012, 318(9), 1040-1048.
160. Ponticelli, C.; Sala, G. Vitamin D: a new player in kidney transplantation? Expert. Rev. Clin. Immunol., 2014, 10(10), 1375-1383.
161. Liu, S.; Gupta, A.; Quarles, L.D. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr. Opin. Nephrol. Hypertens., 2007, 16(4), 329-335.
162. Stubbs, J.; Liu, S.; Quarles, L.D. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin. Dial., 2007, 20(4), 302-308.
163. Viaene, L.; Evenepoel, P.; Meijers, B.; Vanderschueren, D.; Overbergh, L.; Mathieu, C. Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes. Am. J. Nephrol., 2012, 36(6), 497-508.
164. Becher, D.; Deutscher, M.E.; Simpfendorfer, K.R.; Wijburg, O.L.; Pederson, J.S.; Lew, A.M.; Strugnell, R.A.; Walduck, A.K. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Eur. J. Immunol., 2010, 40(10), 2778-2790.
165. Dixit, V.D; Schaffer, E.M; Pyle, R.S.; Collins, G.D.; Sakthivel, S.K.; Palaniappan, R.; Lillard, J.W.; Taub, D.D. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest., 2004, 114(1), 57-66.
166. Carrasco, F.; Basfi-Fer, K.; Rojas, P.; Valencia, A.; Csendes, A.; Codoceo, J.; Inostroza, J.; Ruz, M. Changes in bone mineral density after sleeve gastrectomy or gastric bypass: relationships with variations in vitamin D, ghrelin, and adiponectin levels. Obes. Surg., 2014, 24(6), 877-884.